ORIGINAL RESEARCH
Cell and Organ Transplantology. 2026; 14(1):e2026141192.
DOI: 10.22494/cot.v14-1.192
Platelet-rich fibrin gel as an in situ bioreactor supporting serotonergic neuron survival and neural lineage gene expression in rat mesenchymal stem cells
Usenko O.1
, Khyzhnyak M.2
, Vasylieva I.2
, Oleksenko N.2
, Chopyk N.2
, Tsyubko N.2![]()
- 1Shalimov National Scientific Center of Surgery and Transplantology, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
- 2Romodanov State Institute of Neurosurgery, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
Abstract
Platelet-derived biomaterials are increasingly used in regenerative medicine as bioactive scaffolds capable of modulating cell survival, lineage-associated molecular responses, and tissue repair. Fibrin gels enriched with platelet-derived growth factors represent a promising microenvironment for neural tissue engineering, as they may support neuronal survival and promote neural lineage-associated changes in stem cells.
Objective. To evaluate the ability of a platelet-enriched fibrin gel derived from human platelet-rich plasma to function as a bioactive three-dimensional microenvironment supporting survival and morphogenesis of serotonergic neurons and neural lineage-associated changes in mesenchymal stem cells (MSCs).
Materials and methods. A platelet-enriched fibrin gel matrix was generated from platelet-rich plasma following activation with a silica-based coagulation activator. A platelet-enriched fibrin gel matrix derived from human platelet-rich plasma served as a three-dimensional culture platform for bone marrow-derived MSCs from newborn rats and for primary serotonergic cells isolated from raphe nuclei. Cultures were maintained for up to 14 days. Serotonin production was assessed using ELISA, while expression of genes associated with serotonergic phenotype maintenance (Pet1, Nkx2-2, Tph2, Slc6a4) and neural lineage-associated molecular changes (Nes, Tubb3, Gfap, Olig2) was analyzed by semi-quantitative reverse transcription polymerase chain reaction (RT-PCR).
Results. Raphe-derived cells cultured within the platelet-enriched fibrin gel matrix demonstrated active neurite extension and formation of neuronal networks. Maintenance of a serotonergic phenotype was supported by histochemical detection of serotonin and by persistence of Pet1, Nkx2-2, Tph2, and Slc6a4 expression during the culture period. MSCs cultured within the matrix in the presence of neuroinductive factors (retinoic acid, NGF, and BDNF) exhibited morphological features of neural-like cells and increased expression of early neural (Nes), neuronal (Tubb3), astroglial (Gfap), and oligodendroglial (Olig2) markers compared with control cultures. These findings indicate that platelet-enriched fibrin gel functions as a bioactive three-dimensional microenvironment supporting neuronal survival and neural lineage-associated molecular changes in MSCs and may serve as an in situ bioreactor-like platform for modeling neural regeneration in vitro.
Conclusions. The platelet-enriched fibrin gel matrix provided a bioactive three-dimensional microenvironment that supported survival of serotonergic cells and modulated neural marker expression in MSCs under neuroinductive conditions. These findings are consistent with neural lineage-associated molecular responses, although additional quantitative and functional validation is required to confirm mature neural differentiation.
Keywords: platelet-enriched fibrin gel; mesenchymal stem cells; serotonergic neurons; neural lineage commitment; neural tissue engineering; regenerative medicine
Full text PDF
| 1. Etulain J. Platelets in wound healing and regenerative medicine. Platelets. 2018;29(6):556-568. doi:10.1080/09537104.2018.1430357. https://doi.org/10.1080/09537104.2018.1430357 PMid:29442539 |
||||
| 2. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost. 2011;105(Suppl 1):S13-S33. doi:10.1160/THS10-11-0720. https://doi.org/10.1160/THS10-11-0720 PMid:21479340 |
||||
| 3. Johnson PJ, Tatara A, Shiu A, Sakiyama-Elbert SE. Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing affinity-based delivery systems. J Control Release. 2010;146(2):171-178. doi:10.1016/j.jconrel.2010.05.012. https://doi.org/10.1016/j.jconrel.2010.05.012 PMid:20493218 |
||||
| 4. Samson SC, Khan AM, Mendoza MC. ERK signaling for cell migration and invasion. Front Mol Biosci. 2022;9:998475. doi:10.3389/fmolb.2022.998475. https://doi.org/10.3389/fmolb.2022.998475 PMid:36262472 PMCid:PMC9573968 |
||||
| 5. Wang M, Lin C, Jia X, Zhang L, Chen Y, Li H. HGF/c-Met signaling promotes the migration and proliferation of deer antler MSCs. Sci Rep. 2023;13:11121. doi:10.1038/s41598-023-38116-7. https://doi.org/10.1038/s41598-023-38116-7 PMid:37429874 PMCid:PMC10333329 |
||||
| 6. Wang X, Guan Y, Xiang S, Clark KL, Alexander PG, Lin H. Role of canonical Wnt/β-catenin pathway in regulating chondrocytic hypertrophy in mesenchymal stem cell-based cartilage tissue engineering. Front Cell Dev Biol. 2022;10:812081. doi:10.3389/fcell.2022.812081. https://doi.org/10.3389/fcell.2022.812081 PMid:35141220 PMCid:PMC8820467 |
||||
| 7. Zhou S. TGF-β regulates β-catenin signaling and osteoblast differentiation in human mesenchymal stem cells. J Cell Biochem. 2011;112(6):1651-1660. doi:10.1002/jcb.23079. https://doi.org/10.1002/jcb.23079 PMid:21344492 PMCid:PMC3079785 |
||||
| 8. Saidova AA, Vorobjev IA. Lineage commitment, signaling pathways, and cytoskeleton systems in mesenchymal stem cells. Tissue Eng Part B Rev. 2020;26(1):13-25. doi:10.1089/ten.TEB.2019.0250. https://doi.org/10.1089/ten.teb.2019.0250 PMid:31663422 PMCid:PMC12862248 |
||||
| 9. Borroto-Escuela DO, Pérez-Alea M, Narvaez M, Tarakanov AO, Mudó G, Fuxe K. Enhancement of FGFR1 signaling in the FGFR1-5-HT1A heteroreceptor complex in midbrain raphe 5-HT neuron systems. Biochem Biophys Res Commun. 2015;463(3):180-186. doi:10.1016/j.bbrc.2015.04.133. https://doi.org/10.1016/j.bbrc.2015.04.133 PMid:25957476 |
||||
| 10. Werner H. The IGF1 signaling pathway: from basic concepts to therapeutic opportunities. Int J Mol Sci. 2023;24(19):14882. doi:10.3390/ijms241914882. https://doi.org/10.3390/ijms241914882 PMid:37834331 PMCid:PMC10573540 |
||||
| 11. Wang L, Ruan M, Bu Q, Zhao C. Signaling pathways driving MSC osteogenesis: mechanisms, regulation, and translational applications. Int J Mol Sci. 2025;26(3):1311. doi:10.3390/ijms26031311. https://doi.org/10.3390/ijms26031311 PMid:39941080 PMCid:PMC11818554 |
||||
| 12. Otsuka T, Mengsteab PY, Laurencin CT. Control of mesenchymal cell fate via application of FGF-8b in vitro. Stem Cell Res. 2021;51:102155. doi:10.1016/j.scr.2021.102155. https://doi.org/10.1016/j.scr.2021.102155 PMid:33445073 PMCid:PMC8027992 |
||||
| 13. Lee J, Henderson K, Massidda MW, Armenta-Ochoa M, Im BG, Kim J. Mechanobiological conditioning of mesenchymal stem cells for enhanced vascular regeneration. Nat Biomed Eng. 2021;5(1):89-102. doi:10.1038/s41551-020-00674-w. https://doi.org/10.1038/s41551-020-00674-w PMid:33483713 PMCid:PMC8875880 |
||||
| 14. Alnasser SM, Alrobian AS, Alfayez MS, Almutairi OT, Almutairi SS, Alkeraidees TS. Pharmacological modulation of stem cell signaling pathways for therapeutic applications. Stem Cell Res Ther. 2025;16(1):327. doi:10.1186/s13287-025-04438-8. https://doi.org/10.1186/s13287-025-04438-8 PMid:40598543 PMCid:PMC12210473 |
||||
| 15. Luo J, Li P. Context-dependent transcriptional regulations of YAP/TAZ in stem cells and differentiation. Stem Cell Res Ther. 2022;13(1):10. doi:10.1186/s13287-021-02686-y. https://doi.org/10.1186/s13287-021-02686-y PMid:35012640 PMCid:PMC8751096 |
||||
| 16. Zha K, Yang Y, Tian G, Sun Z, Yang Z, Liu S. Nerve growth factor (NGF) and NGF receptors in mesenchymal stem/stromal cells: impact on potential therapies. Stem Cells Transl Med. 2021;10(7):1008-1020. doi:10.1002/sctm.20-0290. https://doi.org/10.1002/sctm.20-0290 PMid:33586908 PMCid:PMC8235142 |
||||
| 17. Tzeng HH, Hsu CH, Chung TH, Lee WC, Lin CH, Wang JY. Cell signaling and differential protein expression in neuronal differentiation of bone marrow mesenchymal stem cells with hypermethylated Salvador/Warts/Hippo (SWH) pathway genes. PLoS One. 2015;10(12):e0145542. doi:10.1371/journal.pone.0145542. https://doi.org/10.1371/journal.pone.0145542 PMid:26713735 PMCid:PMC4699852 |
||||
| 18. Brown G. Retinoic acid receptor regulation of decision-making for cell differentiation. Front Cell Dev Biol. 2023;11:1182204. doi:10.3389/fcell.2023.1182204. https://doi.org/10.3389/fcell.2023.1182204 PMid:37082619 PMCid:PMC10110968 |
||||
| 19. Zhang Y, Liu Q, Sun W, Zhao M, Han J, Xu L. All-trans retinoic acid pretreatment of mesenchymal stem cells promotes HA production and activates the PI3K/AKT pathway in renal injury. Cell Commun Signal. 2024;22:1671. doi:10.1186/s12964-024-01671-1. https://doi.org/10.1186/s12964-024-01671-1 PMid:38802835 PMCid:PMC11129434 |
||||
| 20. Choi BY, Lee J, Kim SJ, Kim H, Lee S, Park J. Engineered mesenchymal stem cells over-expressing BDNF activate TrkB/PLCγ/AKT/ERK signaling pathways in retinoic acid-induced SH-SY5Y cells. Pharmaceutics. 2023;16(3):436. doi:10.3390/ph16030436. https://doi.org/10.3390/ph16030436 PMid:36986535 PMCid:PMC10054459 |
||||
| 21. Assunção-Silva RC, Gomes ED, Sousa N, Silva NA, Salgado AJ. Hydrogels and cell based therapies in spinal cord injury regeneration. Stem Cells Int. 2015;2015:948040. doi:10.1155/2015/948040. https://doi.org/10.1155/2015/948040 PMid:26124844 PMCid:PMC4466497 |
||||
| 22. AVMA Guidelines for the Euthanasia of Animals: 2020 Edition, p. 58 | ||||
| 23. Jiménez-Acosta M, Hernández L, Cristerna M, Tapia-Ramírez J, Meraz-Ríos M. Review: neuronal differentiation protocols of mesenchymal stem cells. Adv Biosci Biotechnol. 2022;13:15-71. doi:10.4236/abb.2022.131002. https://doi.org/10.4236/abb.2022.131002 |
||||
| 24. Tsintou M, Dalamagkas K, Seifalian AM. Advances in regenerative therapies for spinal cord injury: a biomaterials approach. Neural Regen Res. 2015;10(5):726-742. doi:10.4103/1673-5374.156967. https://doi.org/10.4103/1673-5374.156967 PMid:26109945 PMCid:PMC4468762 |
||||
| 25. Smidt MP, van Hooft JA. Subset specification of central serotonergic neurons. Front Cell Neurosci. 2013;7:200. doi:10.3389/fncel.2013.00200. https://doi.org/10.3389/fncel.2013.00200 |
||||
| 26. Donovan LJ, Spencer WC, Kitt MM, Eastman BA, Lobur KJ, Deneris ES. Lmx1b is required at multiple stages to build expansive serotonergic axon architectures. eLife. 2019;8:e48788. doi:10.7554/eLife.48788. https://doi.org/10.7554/eLife.48788 PMid:31355748 PMCid:PMC6685705 |
||||
| 27. Sharifi M, Kamalabadi-Farahani M, Salehi M, Ebrahimi-Brough S, Alizadeh M. Recent perspectives on the synergy of mesenchymal stem cells with micro/nano strategies in peripheral nerve regeneration: a review. Front Bioeng Biotechnol. 2024;12:1401512. doi:10.3389/fbioe.2024.1401512. https://doi.org/10.3389/fbioe.2024.1401512 PMid:39050683 PMCid:PMC11266111 |
||||
| 28. Son B, Park S, Cho S, Kim J, Baek SH, Yoo KH. Improved neural inductivity of size-controlled 3D human embryonic stem cells using magnetic nanoparticles. Biomater Res. 2024;28:11. doi:10.34133/bmr.0011. https://doi.org/10.34133/bmr.0011 PMid:38500782 PMCid:PMC10944702 |
||||
| 29. Gong M, Bi Y, Jiang W, Zhang Y, Chen L, Hou N, et al. Retinoic acid receptor beta mediates all-trans retinoic acid facilitation of mesenchymal stem cells neuronal differentiation. Int J Biochem Cell Biol. 2013;45(4):866-875. doi:10.1016/j.biocel.2013.01.002. https://doi.org/10.1016/j.biocel.2013.01.002 PMid:23318218 |
||||
| 30. Kamińska A, Radoszkiewicz K, Rybkowska P, Wędzińska A, Sarnowska A. Interaction of neural stem cells (NSCs) and mesenchymal stem cells (MSCs) as a promising approach in brain study and nerve regeneration. Cells. 2022;11(9):1464. doi:10.3390/cells11091464. https://doi.org/10.3390/cells11091464 PMid:35563770 PMCid:PMC9105617 |
||||
| 31. Wang Y, Chen X, Cao W, Shi Y. Plasticity of mesenchymal stem cells in neuroregeneration. Bioengineering (Basel). 2024;11(2):112. doi:10.3390/bioengineering11020112. https://doi.org/10.3390/bioengineering11020112 PMid:38391598 PMCid:PMC10886199 |
||||
| 32. Zhao DZ, Wei HX, Yang YB, Yang K, Chen F, Zhang Q, et al. Advances in the research of mesenchymal stromal cells in the treatment of maxillofacial neurological disorders and the promotion of facial nerve regeneration. Mol Neurobiol. 2025;62:14407-14423. doi:10.1007/s12035-025-04981-8. https://doi.org/10.1007/s12035-025-04981-8 PMid:40295362 PMCid:PMC12511153 |
||||
| 33. Li XH, Xiao HX, Wang ZX, Tang XR, Yu XF, Pan YP. Platelet concentrates preconditioning of mesenchymal stem cells and combined therapies: integrating regenerative strategies for enhanced clinical applications. Cell Transplant. 2024;33:9636897241235460. doi:10.1177/09636897241235460. https://doi.org/10.1177/09636897241235460 PMid:38506426 PMCid:PMC10956156 |
||||
| 34. Zhang L, Yin Y, Zhang H, Wang Q, Zhao Z, Wang Y. Mesenchymal stem cells promote neurite outgrowth through neurotrophic factor secretion. Sci Rep. 2022;12:1845. doi:10.1038/s41598-022-05845-7. | ||||
| 35. Li X, Zhang Y, Liu Z, Chen J, Wang H. Role of mesenchymal stem cells in neuroregeneration and neuroprotection. Front Neurol. 2025;16:1472679. doi:10.3389/fneur.2025.1472679. https://doi.org/10.3389/fneur.2025.1472679 PMid:39974358 PMCid:PMC11835705 |
||||
Usenko O, Khyzhnyak M, Vasylieva I, Oleksenko N, Chopyk N, Tsyubko O. Platelet-rich fibrin gel as an in situ bioreactor supporting serotonergic neuron survival and neural lineage gene expression in rat mesenchymal stem cells. Cell Organ Transpl. 2026; 14(1):e2026141192. doi: https://doi.org/10.22494/cot.v14-1.192

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

